Are CSL shares likely to go up from here? The post Down 11% in 2025, are CSL shares a good buy right now? appeared first on ...

Let's see if analysts think investors should be buying the dip with this quality stock. The post CSL is approaching a 5-year low. Is this a buying opportunity? appeared first on The Motley Fool ...

CSL shares will pay a 9% higher interim dividend of US$1.30 per share on 9 April. Here's when the ASX healthcare giant will go ex-dividend.

Learn More CSL Ltd (ASX: CSL) shares had another poor session on Wednesday. The biotechnology company's shares were down 1.5% to $252.92. This means that they are now down 20% from their 52-week high.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Detailed price information for Esperion Theraptc (ESPR-Q) from The Globe and Mail including charting and trades.

CSL Finance Ltd (Formerly known Consolidated Securities Limited) was incorporated on December 28, 1992. The Company is engaged in the business of providing the finance facilities to small and ...

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

On Wednesday, Morgan Stanley began coverage on CSL Ltd (OTC:CSLLY). (CSL:AU) (OTC: CMXHF), assigning an Overweight rating to the biotechnology company’s shares. The firm has set a price target ...

CSL Finance Ltd share price was up by 5.92% from the previous closing price of ₹250.75. Who are peers of CSL Finance Ltd? The peers of CSL Finance Ltd are Bajaj Finance Ltd, Bajaj Finserv Ltd ...